Menu
Česky English
532 23 1111
Česky English
Areál Bohunice
Dětská nemocnice
Porodnice
Úvodní stránka

Příspěvky na mezinárodních konferencích v roce 2000

Buliková A, Matýšková M, Dušek V, Zavřelová J, Fojtík Z. and all. Antiphospholipid antibodies and thromboses in patrients with rheumatologic diseases and tumors. 16 th International Congress on Thrombosis, May 5-8,Porto, Portugal, abstrakt...

  1. Buliková A, Matýšková M, Dušek V, Zavřelová J, Fojtík Z.  and all. Antiphospholipid antibodies and thromboses in patrients with rheumatologic diseases and tumors. 16 th International Congress on Thrombosis, May 5-8,Porto, Portugal, abstrakt.
  2. Fojtík Z, Buliková A, Matýšková M. and all. Presence of antiphospholipid antibodies in patients with rheumatic diseases. Annual European Congress of Rheumatology, June 21-24, Nice, France, abstrakt č 507.
  3. Fojtík, Z., Bulíková,A., Tobolíková, V., Zavřelová, J.: Laboratory Findings in the “Thrombembolic” and “Non-Thrombembolic” subgroups of patients with antiphospholipid antibodies. 3rd Central European Congress of Rheumatology. Bratislava, Slovakia, May 10-13, 2000, abstrakt, str. 92.
  4. Hájek R., Krejčí M., Ščudla,V. , Bačovský J. et al.: Report from the Trial “4w” of Czech Myeloma Group: Therapy of Multiple Myeloma with high Dose Melphalan and Peripheral Blood Stem Cell (PBSC) Support, Followed Maintenance Therapy With Interferon Alpha –2b (IFN) Monotherapy or Sequential, Maintenance Therapy IFN and Dexamethasone (DEX). Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrkt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 223, abstrakt P 714.
  5. Hájek, R., Žáčková,D., Penka, M., Krahulcová et al: Autologous Transplantation in CML Patients using Interleukin 2 Activated Graft Followed With Il-2 and GM-CSF Immunotherapy. Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrkt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 100, abstrakt P 278.
  6. Klabusay, M.., Doubek, M., Adam, Z.: Peripheral blood plasma cells correlate with the disease activity in patients with multiple myeloma after PBSC transplantation. Acta Haematologica 103 (suppl. 1), 53, 2000
  7. Klabusay, M.., Doubek, M., Adam, Z: Can peripheral blood plasma cells predict a relapse of multiple myeloma in patients after PBSC transplantation? Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrkt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 219, abstrakt P 697.
  8. Klabusay, M.: Peropheral blood plasma cells correspond to the disease activity in patients with multiple myeloma after PBSC transplantation. 13th Symposium on Molecular Biology of Hematopoesis – Treatment of Leukemia, Lymphoma & Cancer, New York, USA, 2000, lecture
  9. Kořístek, Z., Mayer, J., Navrátil, M: Fine needle bone marrow aspiration for prediction of harvest yield. Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrakt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 257, abstrakt P 822.
  10. Křivanová A, Fojtík Z, Adam Z, Prokeš B, Znojil V and all. Influence of clodronate on the bone density of patients with multiple myeloma- three year follow up of the therapeutic effect. World Congress on Osteoporosis 2000,June 15-18, Chicago, Illinois, abstrakt č.536.
  11. Křivanová A., Hájek, R., Adam, Z., et al.: T2 MODEL – A clinical experimentalmodel for evaluation of the effect of the new experimental perspective approaches in multiple myeloma patients (the results of pilot studies Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrkt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 223, abstrakt P 713.
  12. Lalacentte, M., Rezvani, K., Szydlo, R., Mayer, J. et al: Favorable outcome of non-myeloblative stem cell transplant for chronic myeloid leukemia in first chronic phase: a retrospective study of the European Group of Blood and Marrow transplantation. Blood 96, No 11, abstract No 2340.
  13. Mayer, J., Doubek, M., Horký, D., Doubek, J., Scheer P.: Markedly reduced nrphrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures – animal model and clinical study. Blood 96, 2000, No 11, abstract No 5223
  14. Mayer, J., Indrák, K., Koza, V., Lazarus, H., Shea, T. et al: Leridistim vs. G-CSF mobilization of peripheral blood stem cells when used with cyclophosphamide and etoposide in patients with lymphoma. Blood 96, 2000, No 11, abstract No 776.
  15. Mayer, J., Krahulová, M., Kořístek, Z., Dvořáková, D., Freiberger, J., Vorlíček, J.: Allogeneic peripheral blood stem cell transplantation after non-myeloblative regimen containing busulfan, fludarabine, and ATG. Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrkt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 129, abstrakt P 376.
  16. Mayer, J., Vášová, I., Kořístek, Z., Navrátil, M.: Ifo and eto-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma. Workshop on cytoreduction, stem cell mobilization, and high-dose therapy in relapsed/refeactory malignant lymphomas. Ahrenburg (Germany), 12 October, abstact s.7, invited lecture.
  17. Navrátil, M., Vášová, I., Mayer, J.: Toxicity of high-dose regiment BEAM and BuCy 2 in patients with lymphoma-single-center experience. Bone Marrow Transplantation 2000, 26th Annual Meeting European Group for Blood and Marrow Transpl.and 16th Meeting of the Nurses Group. Innsbruck, Austria, March 5-8.3. 2000, abstrkt v Bone Marrow Transplantation 2000, vol. 25, Suppl.1, s. 136, abstrakt P 402.
  18. Skřičková, J., Mayer, J., Vorlíček, J., Merta, Z.: Pulmonary infections in leukemic patients. World Congress on Lung Health and 10th ERS Annual Congress, Florence, Italy, August 30- September 3, 2000, abst. 374.
  19. Skřičková, J., Mayer, J., Vorlíček, J.,Znojil, V., Merta, Z.: Plicní infekce Pneumocystis carinii u HIV negativních nemocných s nádorovým a bez nádorového onemocnění. X. kongres Slovenskej a českej pneumologickej a ftizeologickej spoločnosti, Poprad, Slovensko,7.-10. 10. 2000, abstr. č. 151.
  20. Vorlíček, J., Skřičková, J.: Základy paliativní medicíny. 5.th European Congress of Clinical Gerontology, Bratislava, Juna 22-24, 2000. Geriatria, VI., 2, 2000, Abstracts č. 74

 


FN Brno je státní příspěvková organizace zřízená rozhodnutím Ministerstva zdravotnictví. Nemá zákonnou povinnost zápisu do obchodního rejstříku, je zapsána do živnostenského rejstříku vedeného Živnostenským úřadem města Brna.

Fakultní nemocnice Brno - snadné čtení (dle metodiky „Easy to read“) Srozumitelné informace

Bohunice Dětská nemocnice Porodnice

Jihlavská 20, Brno
Telefon: 532 23 1111
E-mail:

Nastavení soukromí

© Fakultní nemocnice Brno. Všechna práva vyhrazena. | developed by Via Aurea s.r.o.

Informace o pohotovosti v Brně a Jihomoravském kraji